Group structure
17 companies in 12 countries
Loading…
17 companies in 12 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 127
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALLEGRA | Fexofenadine | Brazil | Authorised | 2023 |
| ALLEGRA 12 HOUR60 mg · Tablet | Fexofenadine | Canada | Marketed | 1997 |
| Allegra 120 mg filmom obložene tabletefilmom obložena tableta | Fexofenadine | Croatia | Authorised | 2021 |
| ALLEGRA 24 HOUR120 mg · Tablet | Fexofenadine | Canada | Marketed | 2001 |
| ALLEGRA D | Fexofenadine, Pseudoephedrine | Brazil | Authorised | 2023 |
| Allegra fexotabs, 120 mg filmomhulde tablettenFilmomhulde tablet | Fexofenadine | Netherlands | Authorised | 1997 |
| ALLEGRA HIVES60 mg · Tablet | Fexofenadine | Canada | Marketed | 2023 |
| ALLENASAL | Triancinolona acetonida | Brazil | Authorised | 2023 |
| ANADOR | Dipirona | Brazil | Authorised | 2023 |
| Bisolaclar 600 mg bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2015 |
| Bisolbruis 600 mg bruistablettenBruistablet | Acetylcysteine | Netherlands | Authorised | 2014 |
| BISOLGRIP FORTE GRANULADO PARA SOLUCION ORAL650 mg + 4 mg + 15,58 mg · Granulado para solución oral | Paracetamol, Chlorpheniramine, Fenilefrina bitartrato | Spain | Marketed | 2013 |
| BISOLGRIP GRANULADO PARA SOLUCION ORAL500 mg + 15,58 mg + 4 mg · Granulado para solución oral | Paracetamol, Fenilefrina bitartrato, Chlorpheniramine | Spain | Authorised | 2022 |
| Bisolnasal met eucalyptus, neusspray oplossing 1,18 mg/mlNeusspray, oplossing | Tramazoline | Netherlands | Authorised | 1998 |
| BISOLPHYTO JARABE29,2 mg/ml + 3,6 mg/ml · Jarabe | Tomillo extracto seco, Althaea officinalis l. extracto seco | Spain | Authorised | 2026 |
| BISOLVON | Bromexina | Brazil | Authorised | 2023 |
| Bisolvon 2 mg/ml oralna otopina/koncentrat za otopinu za atomizatororalna otopina/koncentrat za otopinu za atomizator | Bromhexine | Croatia | Marketed | 2021 |
| Bisolvon 4 mg/5 ml sirupsirup | Bromhexine | Croatia | Marketed | 2021 |
| Bisolvon 8 mg tabletetableta | Bromhexine | Croatia | Marketed | 2021 |
| BISOLVON ANTITUSIVO 2 mg/ ml JARABE10 mg · Jarabe | Dextromethorphan | Spain | Marketed | 1988 |
| BISOLVON ANTITUSIVO COMPOSITUM 3 mg/ml + 1,5 mg/ml SOLUCION ORAL15,75 mg + 7,50 mg · Solución oral | Dextromethorphan, Diphenhydramine | Spain | Marketed | 2008 |
| BISOLVON CALMATOS 2,13 MG/ML SOLUCION ORAL2,13 mg/ml · Solución oral | Pentoxiverina | Spain | Authorised | 2022 |
| Bisolvon drank, 8 mg/5 mlDrank | Bromhexine | Netherlands | Authorised | 1982 |
| Bisolvon drank voor kinderen met aardbeiensmaak, 4 mg/5 mlDrank | Bromhexine | Netherlands | Authorised | 2010 |
| BISOLVON MUCOLITICO 1,6 mg/ ml JARABE8,0 mg · Jarabe | Bromhexine | Spain | Marketed | 2005 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 55 | 31 | 24 | CompaniesAll medicines |
| Brazil | 23 | 21 | 2 | CompaniesAll medicines |
| Netherlands | 20 | 20 | 0 | CompaniesAll medicines |
| Singapore | 13 | 13 | 0 | CompaniesAll medicines |
| Croatia | 9 | 9 | 0 | CompaniesAll medicines |
| Canada | 7 | 7 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, France, Italy, Malaysia, Serbia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Report an error or request removalCorrections from the company itself are welcome.
Keep Opella’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callInstituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM renovacion; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history
GLEIF; exact source URL and retrieval date; no endorsement.
Licence: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence: CC0
Well-known pharmaceutical groups, each with all its companies.